In a significant milestone for health technology innovation, Australis Scientific has successfully raised $6,000,000 in funding to advance its groundbreaking InConfidence Smart Patch, designed to transform the management of lower urinary tract symptoms (LUTS). Founded by an elite team of Harvard Medical School Health Tech Fellows, Australis Scientific is dedicated to enhancing the quality of life for patients experiencing LUTS, which include frequent urination, urgent urges, and nocturia. With this new funding, the company aims to propel the development and commercialization of their Smart Patch technology, likening its potential impact to that of Continuous Glucose Monitoring (CGM) in diabetes management.
The InConfidence Smart Patch offers a revolutionary approach to help patients take control of their symptoms and manage incontinence more effectively, combining advanced sensors and analytics to deliver personalized insights and care recommendations. By facilitating real-time monitoring of bladder activity, the InConfidence Smart Patch empowers patients to understand their individual patterns and triggers, resulting in better-informed treatment decisions. This infusion of capital will support critical clinical trials and accelerate manufacturing capabilities, bringing the promise of this innovative solution closer to patients in need. As Australis Scientific moves forward, it remains steadfast in its mission to redefine the standard of care for LUTS, ensuring that patients not only have access to cutting-edge technology but also regain confidence in managing their health and well-being.
